Estimates of absolute cause-specific risk in cohort studies.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Biometrics

• Publication date

  1990-09-01

• Fields of study

  Medicine, Mathematics

• Identifiers
  DOI 10.2307/2532098PMID 2242416
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nonparametric Estimation of Transition Intensities and Transition Probabilities: A Case Study of a Two‐State Markov Process

  1989cited by this paper
• Likelihood-based confidence intervals for functions of many parameters

  1988cited by this paper
• A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

  1988influential reference
• Variance Calculations for Direct Adjusted Survival Curves, with Applications to Testing for No Treatment Effect

  1986cited by this paper
• Prognostic factors in patients with resected stage I non‐small cell lung cancer. A report from the Lung Cancer Study Group

  1984cited by this paper
• Unbiased assessment of treatment effects on disease recurrence and survival in clinical trials.

  1983cited by this paper
• What price Kaplan-Meier?

  1983cited by this paper
• Corrected group prognostic curves and summary statistics.

  1982cited by this paper
• Adjusted survival curve estimation using covariates.

  1982cited by this paper
• Commentary on Andersen and Gill's "Cox's Regression Model for Counting Processes: A Large Sample Study"

  1982cited by this paper
• Survival analysis by sex, age group and hemotype in sickle cell disease.

  1981cited by this paper
• A Large Sample Study of Cox's Regression Model

  1981cited by this paper
• Censoring and stochastic integrals

  1980cited by this paper
• Nonparametric Estimation of Partial Transition Probabilities in Multiple Decrement Models

  1978cited by this paper
• An Empirical Transition Matrix for Non-homogeneous Markov Chains Based on Censored Observations

  1978cited by this paper
• The analysis of failure times in the presence of competing risks.

  1978cited by this paper
• Mathematical Centre Tracts

  1976cited by this paper
• A Large Sample Study of the Life Table and Product Limit Estimates Under Random Censorship

  1974cited by this paper
• Regression models and life tables (with discussion

  1972cited by this paper
• Introduction to stochastic processes in biostatistics.

  1968cited by this paper
• Linear statistical inference and its applications

  1965cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958influential reference

• VLDL cholesterol and ASCVD risk: A population-based study.

  2026cites this paper
• Risk functions with outcome measurement error

  2026cites this paper
• A comparison of modeling approaches for static and dynamic prediction of central-line bloodstream infections using electronic health records (part 1): regression models

  2025cites this paper
• Development and validation of a risk prediction algorithm for high-risk populations combining genetic and conventional risk factors of cardiovascular disease

  2025influential citation
• Impact of duration of untreated illness on clinical and physical measures in early adult patients with major depressive disorder: a large-scale cross-sectional study.

  2025cites this paper
• Building absolute breast cancer risk prediction models for women treated with chest radiation for Hodgkin lymphoma.

  2025cites this paper
• Handbook of Statistics in Clinical Oncology

  2025cites this paper
• Birthweight and risk of chronic kidney disease after a type 2 diabetes diagnosis in the DD2 cohort

  2025cites this paper
• Risk reduction of ASCVD attributed to lowering of remnant cholesterol from statins, fibrates, APOC3 inhibitors, and ANGPTL3 inhibitors: a cohort study.

  2025cites this paper
• Right Censoring and Mortality in the Multicenter AIDS Cohort Study and Women’s Interagency HIV Study

  2025cites this paper
• A Practical Guide to Competing Risk Analysis for Transplant and Cell Therapy Research.

  2025cites this paper
• Risk Stratification for Trial Enrichment Considering Loco‐Regional Failure in Head and Neck Cancer: UICC8 Versus Purpose‐Built Failure‐Type Specific Risk Prediction Model

  2025cites this paper
• The Impact of Prolonged Duration of Untreated Illness on Clinical Correlates in Chronic Schizophrenia: Exploring the Relationship With Suicide Risk

  2024cites this paper
• A comparison of regression models for static and dynamic prediction of a prognostic outcome during admission in electronic health care records

  2024cites this paper
• Joint analysis of multivariate longitudinal, imaging, and time-to-event data

  2024cites this paper
• Familial risk of sinus node dysfunction indicating pacemaker implantation: a nationwide cohort study

  2024cites this paper
• Genome-wide Polygenic Risk Scores Predict Risk of Glioma and Molecular Subtypes.

  2024cites this paper
• Improving Pediatric Normal Tissue Radiation Dose-Response Modeling in Children With Cancer: A PENTEC Initiative.

  2024cites this paper
• Genome-wide Polygenic Risk Scores Predict Risk of Glioma and Molecular Subtypes

  2024cites this paper
• Low birthweight in patients with type 2 diabetes is associated with elevated risk of cardiovascular events and mortality

  2024cites this paper
• The joint survival super learner: A super learner for right-censored data

  2024cites this paper
• Heart Failure Following Anti-Inflammatory Medications in Patients With Type 2 Diabetes Mellitus.

  2023cites this paper
• Software Application Profile: dynamicLM—a tool for performing dynamic risk prediction using a landmark supermodel for survival data under competing risks

  2023cites this paper
• concrete: Targeted Estimation of Survival and Competing Risks in Continuous Time

  2023cites this paper
• Duration of untreated illness and clinical correlates in first-episode and drug-naïve patients with major depressive disorder.

  2023cites this paper
• Asymptotic properties of resampling‐based processes for the average treatment effect in observational studies with competing risks

  2023cites this paper
• The effect of herpes zoster vaccination on the occurrence of deaths due to dementia in England and Wales

  2023cites this paper
• Temporal Trends in Noncardiovascular Morbidity and Mortality Following Acute Myocardial Infarction.

  2023cites this paper
• Lung Cancer Risk Prediction Models for Asian Ever-Smokers.

  2023cites this paper
• Resampling-based confidence intervals and bands for the average treatment effect in observational studies with competing risks

  2023cites this paper
• Patient mortality following new‐onset heart failure stratified by cancer type and status

  2023cites this paper
• Risk of Worsening Heart Failure and All-Cause Mortality Following COVID-19 Vaccination in Patients With Heart Failure: A Nationwide Real-World Safety Study

  2023cites this paper
• A review of risk concepts and models for predicting the risk of primary stroke

  2022cites this paper
• A practical guide to handling competing events in etiologic time-to-event studies

  2022cites this paper
• Prediction of cardiovascular events from systolic or diastolic blood pressure

  2022cites this paper
• Risk Models Based on Non-Cognitive Measures May Identify Presymptomatic Alzheimer’s Disease

  2022cites this paper
• Different human papillomavirus types share early natural history transitions in immunocompetent women

  2022cites this paper
• Lower levels of small HDL particles associated with increased infectious disease morbidity and mortality: a population-based cohort study of 30 195 individuals.

  2022cites this paper
• Surv‐CRM‐12: A Bayesian phase I/II survival CRM for right‐censored toxicity endpoints with competing disease progression

  2022cites this paper
• Risk models based on non-cognitive measures may identify presymptomatic 1 Alzheimer’s disease

  2022cites this paper
• Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study

  2022cites this paper
• Seamless phase I/II design for novel anticancer agents with competing disease progression

  2021cites this paper
• Does the occurrence of a severe asthma exacerbation change the rate of subsequent events?

  2021cites this paper
• Ranking of average treatment effects with generalized random forests for time‐to‐event outcomes

  2021cites this paper
• Prediction of first cardiovascular disease event in 2.9 million individuals using Danish administrative healthcare data: a nationwide, registry-based derivation and validation study

  2021cites this paper
• Outcomes of prolonged dual anti-platelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a nationwide registry-based study.

  2021cites this paper
• Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study

  2021cites this paper
• Robust Bayesian estimation of cumulative incidence function for competing risk data with missing causes

  2021cites this paper
• Cause-specific hazard regression estimation for modified Weibull distribution under a class of non-informative priors

  2021cites this paper
• Competing Hazards Regression Parameter Estimation Under Different Informative Priors

  2021cites this paper
• Personalised need of care in an ageing society: The making of a prediction tool based on register data

  2021cites this paper
• Development and Validation of a Breast Cancer Risk Prediction Model for Childhood Cancer Survivors Treated With Chest Radiation: A Report From the Childhood Cancer Survivor Study and the Dutch Hodgkin Late Effects and LATER Cohorts

  2021cites this paper
• iCARE: An R package to build, validate and apply absolute risk models

  2020cites this paper
• Estimating a Set of Mortality Risk Functions with Multiple Contributing Causes of Death

  2020cites this paper
• Optimality of testing procedures for survival data in the nonproportional hazards setting

  2020cites this paper
• All-cause mortality, stroke, and bleeding in patients with atrial fibrillation and valvular heart disease.

  2020cites this paper
• Pan-cancer analysis demonstrates that integrating polygenic risk scores with modifiable risk factors improves risk prediction

  2020cites this paper
• Survival Analysis II

  2020cites this paper
• Integration of polygenic risk scores with modifiable risk factors improves risk prediction: results from a pan-cancer analysis

  2020cites this paper
• Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry

  2020cites this paper
• A Framework for the Evaluation of Statistical Prediction Models.

  2020cites this paper
• Catheter ablation and mortality, stroke and heart failure readmission with atrial fibrillation

  2020cites this paper
• Linking early life risk factors to frailty in old age: evidence from the China Health and Retirement Longitudinal Study.

  2020cites this paper
• Hydroxychloroquine with or without azithromycin and in-hospital mortality or discharge in patients hospitalized for COVID-19 infection: a cohort study of 4,642 in-patients in France

  2020cites this paper
• Ticagrelor and The Risk of Staphylococcus Aureus Bacteremia and Other Infections.

  2020cites this paper
• Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma.

  2019cites this paper
• Vitamin K Antagonists versus Direct Oral Anticoagulants After Transcatheter Aortic Valve Implantation in Atrial Fibrillation.

  2019cites this paper
• Nonparametric estimation of the cumulative incidence function under outcome misclassification using external validation data

  2019influential citation
• On the estimation of average treatment effects with right‐censored time to event outcome and competing risks

  2019cites this paper
• Optimality of testing procedures for survival data

  2019cites this paper
• Fine–Gray proportional subdistribution hazards model for competing risks data under length-biased sampling

  2019cites this paper
• Clinical implications of electrocardiographic bundle branch block in primary care

  2019cites this paper
• Estimation of the adjusted cause‐specific cumulative probability using flexible regression models for the cause‐specific hazards

  2019cites this paper
• Summarizing and communicating on survival data according to the audience: a tutorial on different measures illustrated with population-based cancer registry data

  2019cites this paper
• Estimating and Testing Vaccine Sieve Effects Using Machine Learning

  2019cites this paper
• Personalized and typical concurrent risk of limitations in social activity and mobility in older persons with multiple chronic conditions and polypharmacy.

  2019cites this paper
• Early Life Environments and Frailty in Old Age among Chinese Older Adults

  2019cites this paper
• Aalborg Universitet Associations between common ECG abnormalities and out-of-hospital cardiac arrest

  2019cites this paper
• Adjusted-crude-incidence analysis of multiple treatments and unbalanced samples on competing risks

  2019cites this paper
• Competing risks analysis of time-to-event data for cardiovascular surgeons.

  2019cites this paper
• On the interpretation of the hazard ratio in Cox regression

  2019cites this paper
• Reduced risk of gastrointestinal bleeding associated with proton pump inhibitor therapy in patients treated with dual antiplatelet therapy after myocardial infarction.

  2019cites this paper
• Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide study.

  2019cites this paper
• Bayesian optimality of testing procedures for survival data

  2019cites this paper
• Competing Risk Regression Models

  2019cites this paper
• Associations between common ECG abnormalities and out-of-hospital cardiac arrest

  2019cites this paper
• Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study

  2018cites this paper
• Interpretation of exposure effect in competing risks setting under accelerated failure time models

  2018cites this paper
• Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study

  2018cites this paper
• Research Questions in Data Science

  2018cites this paper
• Targeted Estimation of Cumulative Vaccine Sieve Effects

  2018cites this paper
• Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study

  2018cites this paper
• Risk Prediction of Atrial Fibrillation Based on Electrocardiographic Interatrial Block

  2018cites this paper
• Data-Adaptive Estimation in Cluster Randomized Trials

  2018cites this paper
• Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study

  2018cites this paper
• Long‐term use of proton pump inhibitors, dose–response relationship and associated risk of ischemic stroke and myocardial infarction

  2018cites this paper
• The index of prediction accuracy: an intuitive measure useful for evaluating risk prediction models

  2018cites this paper
• Predicting recovery from acute kidney injury in critically ill patients: development and validation of a prediction model.

  2018cites this paper
• A failure-type specific risk prediction tool for selection of head-and-neck cancer patients for experimental treatments.

  2017cites this paper
• Risk factors and predictors of dementia and cognitive impairment

  2017cites this paper